Richard S. Lindahl - EVP, Chief Financial Officer at Emergent BioSolutions Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
EVP, Chief Financial Officer
Stock Symbol
EBS on NYSE
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Richard S. Lindahl since 12/23/2023

Holdings reported by Richard S. Lindahl for Emergent BioSolutions Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 171K $1.39M $8.13 Oct 15, 2024 Direct
Employee Stock Options (Right to Buy) 306K Mar 13, 2024 Direct Common Stock

Transactions reported by Richard S. Lindahl for Emergent BioSolutions Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.